Difference between revisions of "Category:Hedgehog pathway inhibitors"
Jump to navigation
Jump to search
Warner-admin (talk | contribs) |
Warner-admin (talk | contribs) m (Text replacement - "Category:Targeted therapy" to "Category:Targeted therapeutic") |
||
| Line 1: | Line 1: | ||
A class of drugs that target one or more components of the Hedgehog signaling pathway. Vismodegib is the first in class to be FDA approved. | A class of drugs that target one or more components of the Hedgehog signaling pathway. Vismodegib is the first in class to be FDA approved. | ||
| − | [[Category:Targeted | + | [[Category:Targeted therapeutic]] |
Latest revision as of 01:19, 29 February 2020
A class of drugs that target one or more components of the Hedgehog signaling pathway. Vismodegib is the first in class to be FDA approved.
Pages in category "Hedgehog pathway inhibitors"
The following 3 pages are in this category, out of 3 total.